Search For "dcgi"
SEC recommends Phase 1 clinical trials of Reliance's Covid Vaccine candida
Updated : 4 years, 6 months ago IST
New Delhi [India], August 27 (ANI): The Subject Expert Committee (SEC) has recommended Phase 1 clinical trials of Reliance's recombinant COVID-19 vaccine candidate.
Read More
Adolescents likely to get ZyCoV-D COVID vaccine after four weeks
Updated : 4 years, 6 months ago IST
New Delhi [India], August 23 (ANI): The Drugs Controller General of India (DCGI) on Friday approved Zydus Cadila's DNA vaccine for emergency use in adults and children aged 12 years and above.
Read More
Will take another 4-5 months to publish phase 3 trials data of ZyCoV-D vac
Updated : 4 years, 6 months ago IST
New Delhi [India], August 21 (ANI): Managing Director of Zydus Group Dr Sharvil Patel on Saturday said that his firm will soon apply for the Indian drug regulator's approval to conduct trials of ZyCoV-D on children above 2 years and added that it will take another 4-5 months to publish the p
Read More
India approves Zydus Cadila's ZyCoV-D vaccine for emergency use for adults
Updated : 4 years, 6 months ago IST
New Delhi [India], August 20 (ANI): Zydus Cadila's wait for a regulatory nod for its ZyCoV-D plasmid DNA vaccine against Covid is over. The Ahmedabad-based pharma company has received approval from the Drugs Controller General of India (DCGI).
Read More
Enzene Biosciences Ltd. obtains Marketing Authorization for its Romiplosti
Updated : 4 years, 6 months ago IST
Pune (Maharashtra) [India], August 20 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its second biosimilar drug "Romiplostim", indicated for the treatment of chronic Immune Thrombocyt
Read More
Zydus Cadila submits additional data to DCGI for its COVID-19 vaccine: Sou
Updated : 4 years, 7 months ago IST
New Delhi [India], July 27 (ANI): Ahmedabad-based Zydus Cadila has submitted additional data related to immunogenicity and safety, on its three-dose COVID-19 vaccine ZyCoV-D, to India's drug regulator Drugs Controller General of India (DCGI), sources said on Tuesday.
Read More
Zydus Cadila expected to provide additional data on Covid-19 vaccine to DC
Updated : 4 years, 7 months ago IST
New Delhi [India], July 20 (ANI): Emergency approval for Zydus Cadila's Covid-19 vaccine may take a few more days with the Ahmedabad-based pharma company set to submit additional data related to immunogenicity and safety of its Zycov-D vaccine to the Drugs Controller General of India (DCGI)
Read More
DCGI examining Zydus Cadila's COVID vaccine for children, says Dr VK Paul
Updated : 4 years, 8 months ago IST
New Delhi [India], July 16 (ANI): Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
Read More
Pfizer, Johnson and Johnson yet to apply for license of COVID-19 vaccines
Updated : 4 years, 8 months ago IST
New Delhi [India], July 15 (ANI): The Drug Controller General of India (DCGI) has urged Pfizer, Johnson and Johnson twice in writing to apply for emergency use authorisation for their COVID-19 vaccine so that application is processed well in time but pharma companies have not applied for
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 8 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More